430 results on '"Quindós, G."'
Search Results
2. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients
3. Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
4. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
5. Validation of the PCR–dHPLC method for rapid identification of Candida glabrata phylogenetically related species in different biological matrices
6. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients
7. Identification of Antigens Reacting with Anti-Candida albicans Germ Tube Antibodies
8. In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris
9. ANTIFUNGAL ACTIVITY IN VITRO OF STATINS: A COMPARATIVE STUDY OF SIMVASTATIN, FLUVASTATIN, LOVASTATIN, PRAVASTATIN AND ATORVASTATIN AGAINST CANDIDA: 104
10. Fungal co-infection in COVID-19 patients: Should we be concerned?
11. New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi
12. In Vitro Activity of a New Liposomal Nystatin Formulation Against Opportunistic Fungal Pathogens
13. First isolation in the Iberian Peninsula of Candida nivariensis from a malnourished patient suffering from a catheterassociated candidaemia: P451
14. Biofilm production and phospholipase and protease activities in Candida parapsilosis sensu stricto blood isolates: P229
15. In vitro antifungal activities of four triazoles and four natural compounds from essential oils against oral Candida isolates: P043
16. Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses
17. Impact of Aspergillusspp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia
18. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods
19. Evaluation of a commercial medium for identification ofCandida species
20. In vitro interaction of micafungin and fluconazole against Candida
21. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One™
22. Usefulness of chromogenic agar Candida ID2 for differentiating Candida dubliniensis from Candida albicans: R2113
23. Microbial colonization of laryngectomy stomas: P1345
24. Supplementation of CHROMagar with Palʼs medium for rapid identification of Candida dubliniensis: O149
25. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods
26. In vitro activities of fluconazole and voriconazole against Spanish bloodstream isolates of Candida glabrata and Candida krusei
27. In vitro susceptibility ofAeromonas caviae, Aeromonas hydrophila andAeromonas sobria to fifteen antibacterial agents
28. Value of detection of antibodies toCandida albicans germ tube in the diagnosis of systemic candidosis
29. Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns
30. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods
31. Comparison of morphotypic and genotypic methods for strain delineation in Candida
32. EPICO 4.0. 'Total quality' in the management of invasive candidiasis in critically ill patients by analysing the integrated process
33. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients
34. EPICO 3.0. Management of non-neutropenic patients in medical wards (vol 33, pg 216, 2016)
35. Biotype Diversity of Candida parapsilosis and Its Relationship to the Clinical Source and Experimental Pathogenicity
36. A multi-center study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin; caspofungin and micafungin using the Sensititre® YeastOne colorimetric method
37. In Vitro Fungicidal Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis Evaluated by Time-Kill Studies
38. Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves
39. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
40. Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative
41. Combination antifungal therapy: A strategy for the management of invasive fungal infections
42. Detection of antibodies toCandida albicans germ tube in the diagnosis of systemic candidiasis
43. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
44. Prospective multicenter study of the epidemiology; molecular identification; and antifungal susceptibility of Candida parapsilosis; Candida orthopsilosis; and Candida metapsilosis isolated from patients with candidemia
45. Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010
46. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
47. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
48. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method
49. Actividad antifúngica in vitro de micafungina
50. Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.